Motor dysfunction in elderly patients with chronic musculoskeletal system diseases (locomotive syndrome)

Locomotive syndrome (LS) is defined as an unsatisfactory condition in patients after the age of 60 years, in which they require or may require physical assistance soon due to deterioration in the functional state of the musculoskeletal system, including pathology of bone tissue, joints, muscles, and the nervous system. The problem of LS treatment in elderly patients is relevant for all countries over the world. The presence of chronic somatic and neurological diseases in most older adults can complicate LS assessment and reduce treatment effectiveness. The patient's functional status and ability to continue activities of daily living  should be assessed at the first visit to determine the degree of  independence, the level of need for caregivers, and the overall  quality of life. LS treatment should be permanent and include  kinesiotherapy, professional psychological support, and complex  drug therapy. The use of vital micronutrients, which include highly  purified forms of chondroitin sulfate and glucosamine sulfate,  which have a wide range of anti-inflammatory and regenerative  effects, can provide the safety of long-term drug therapy.